The jejunal morphological and functional response to either a gluten-free diet or corticosteroid therapy was studied in six patients with dermatitis herpetiformis. In each treatment group there were two patients with subtotal villous atrophy and one with partial villous atrophy. After treatment, in both groups, morphological improvement was seen in villous and surface cell heights, mucosal thickness, and intraepithelial lymphocyte counts. Jejunal function was assessed using the perfusion technique. Absorption of glucose from a 56 mM solution was shown to improve. Water movement from this solution was in a secretory state in four patients (two in each group) before treatment and moved into the normal absorptive range after treatment. These results further outline the similarity between the mucosal lesion of dermatitis herpetiformis and true coeliac disease.
The association of coeliac disease with dermatitis herpetiformis is now well recognized (Marks, Shuster, and Watson, 1966; Fraser, Murray, and Alexander, 1967; Fry, Keir, McMinn, Cowan, and Hoffbrand, 1967) but the intestinal mucosal lesion is often less severe and overt malabsorption is unusual. The relationship between the two conditions and the factors dictating the severity of their manifestations in the gut in the majority of patients remain obscure. The jejunal mucosa in dermatitis herpetiformis has been shown to respond to gluten withdrawal in the majority of patients (Fry, McMinn, Cowan, and Hoffbrand, 1969; Shuster, Watson, and Marks, 1968; Marks and Whittle, 1969) , and relapse when gluten is reintroduced (Fry et al, 1969) . The report of a patchy jejunal lesion in dermatitis herpetiformis (Brow, Parker, Weinstein, and Rubin, 1971) has, however, cast doubt upon the validity of accepting mucosal improvement as judged by a single biopsy specimen and has once again raised the question of the relationship of the gut lesion to dietary gluten.
Because of the possibility of sampling errors due to a patchy lesion, this study was undertaken using both morphological and functional criteria to assess Received for publication 4 January 1973. the significance of gluten withdrawal. Function was assessed using the perfusion technique, as routine tests of absorption are often normal. Furthermore, in view of the observation that an improvement in jejunal morphology occurs in true coeliac disease treated with corticosteroids (Wall, Douglas, Booth, and Pearse, 1970) , we have also assessed the effect of this treatment on the structure and function of the jejunal mucosa in dermatitis herpetiformis to see if there was a similar response.
Patients
Six male patients (aged 32 to 62 years) with dermatitis herpetiformis were studied. The diagnosis of the skin lesion was made on the clinical picture, the usual histological criteria on skin biopsy, and response to dapsone. None had clinical evidence of malabsorption. One group of three patients were treated with a gluten-free diet and one group of three with corticosteroids.
Patients on the gluten-free diet were assessed separately by a dietician and a physician three weeks after starting the diet and two monthly thereafter. The periods of treatment before reinvestigation were three months (W.C.), six months (C.P.), and 15 months (D.M.).
Patients on corticosteroids maintained a normal diet and were reinvestigated after three weeks (P.C.) and six weeks (B.B. and R.B.). The dose used was 60 mg/day of prednisolone for one week, with weekly reductions of 15 mg to a dose of 15 mg when it was tailed off by reductions of 5 mg over the next three weeks. The patients were carefully monitored on weekly visits. All patients gave their informed consent.
Jejunal Biopsies
Jejunal biopsies were performed using the Crosby capsule and samples were taken just distal to the duodeno-jejunal flexure. They were first examined with a dissecting microscope, photographed, and then studied histologically.
Pre-and posttreatment biopsies were performed on the day before the functional assessment.
Morphological Assessment
The villous height, surface cell height, and mucosal thickness were blindly evaluated using the criteria laid down by Stewart, Pollock, Hoffbrand, Mollin, and Booth (1967) . Counts of intraepithelial lymphocytes per 100 villous cells were also performed (Ferguson and Murray, 1971) .
Functional Assessment
Jejunal function was assessed using a double-lumen perfusion technique with a proximal occlusive balloon (Sladen and Dawson, 1970) (Kumar, Silk, Clark, and Dawson, 1972) .
Chemical Methods
Glucose and electrolytes were measured by standard methods in the routine laboratory. Polyethylene glycol was measured by the turbidimetric method of Hyden (1956) .
Results

MORPHOLOGY
In each group there were two patients with subtotal villous atrophy. Patients C.P. and D.M. were treated with a gluten-free diet and patients P.C. and R.B. with corticosteroids. The other two patients showed partial villous atrophy. Repeat biopsies from the same region in five of these patients before treatment (B.B., R.B., D.M., C.P., P.C.) yielded identical histology and no evidence of a patchy lesion. Five patients, regardless of the length or type of treatment, showed improvement in surface cell heights and villous heights and the mucosal thickness showed a decrease towards normal (see table fig. 1) . The pretreatment levels of glucose absorption were below normal in one and normal in the two other patients treated with a gluten-free diet, despite the grossly abnormal biopsies, while in 70 to o0 wC the corticosteroid treated group all patients showed a low glucose absorption before treatment. One patient (W.C.) showed a dramatic improvement in glucose absorption, from below normal to above the normal range. The improvement in jejunal function would seem more striking when we consider water absorption ( fig. 2) . Before treatment all patients showed grossly abnormal water absorption from the glucose perfusate, and four of the six subjects showed a secretory state. Following either therapy all patients improved their absorption to well within the normal range, and even D.M. showed some improvement and just reached the lower limit of normal. (Fry, with either a Seah, McMinn, and Hoffbrand, 1972) but the shaded area numbers here are too small to compare the relative effects of gluten withdrawal and steroid therapy. The functional significance of this morphological improvement was shown by an improvement in the absorption of glucose. It is interesting that before treatment two of the six patients showed a normal glucose absorption, despite total villous atrophy, and we have previously reported that a number of patients with grossly abnormal mucosae showed no abnormality of function in the area of proximal jejunum that was perfused (Kumar et al, 1972 (Brow et al, 1971 ). The majority of the patients, that is 15 of 22, showed a flat jejunal mucosa on all biopsies. In our series, so far, no evidence of a patchy lesion has been found and we would think that this is unusual in dermatitis herpetiformis. The findings here again suggest that a similarity between the mucosal lesion of dermatitis herpetiformis and true coeliac disease exists and both improve morphologically and functionally when treated with either a gluten-free diet or corticosteroid therapy.
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